According to the Legislative Budget Board (LBB), SB 922 is not expected to have a significant fiscal impact on the State of Texas. The analysis concludes that any administrative costs or implementation efforts required by the legislation—such as configuring electronic health record systems to comply with the mandated three-day delay for sensitive test result disclosures—can be absorbed within existing resources by relevant state agencies, such as the Texas Medical Board.

Furthermore, the bill carries no anticipated fiscal implications for local governments. This indicates that counties, municipalities, or other local entities that operate healthcare facilities or contract with providers are not expected to incur additional expenses in complying with the legislation. This low-cost implementation is likely due to the fact that most healthcare systems already utilize electronic health record platforms capable of managing timed releases of information.

In summary, SB 922 imposes a policy shift in how and when sensitive medical information is disclosed electronically but does so without creating new financial burdens for state or local agencies.

SB 922 attempts to address a very human concern: the distress patients may experience when receiving serious medical news—such as the possibility of cancer—via impersonal electronic means. The author frames the bill as a response to federal overreach under the 21st Century Cures Act, which mandates real-time disclosure of electronic health information. By imposing a three-day delay for the electronic release of certain “sensitive” test results, the bill seeks to create a window in which physicians can personally contact patients and contextualize difficult news.

However, while the motivation may be compassionate, the mechanism is fundamentally flawed from a liberty and limited government perspective. The bill overrides the personal choice of individuals to access their own medical information when and how they see fit. Many healthcare systems already offer patients the option to delay access or receive information directly from a provider, preserving autonomy and tailoring care to personal preferences. SB 922 transforms this option into a blanket restriction by law, denying all patients access unless the data is delivered in person or outside the designated electronic systems.

Moreover, the legislation unnecessarily inserts the state into private-sector operations and the doctor-patient relationship, areas that are best governed by professional ethics, individual consent, and market practices. It also sets a concerning precedent for further state control over the timing and method of health communication without strong justification or evidence of broad public harm.

For these reasons, while the bill is well-meaning, Texas Policy Research recommends that lawmakers vote NO on SB 922. The appropriate role of government is not to mediate the timing of sensitive information between patients and doctors, especially when voluntary, private solutions already exist.

• Individual Liberty: The bill directly restricts a patient's ability to access their own sensitive medical information in real time via electronic means, such as patient portals or apps. While well-intentioned, this delay overrides the individual’s right to make informed decisions about their health on their own timeline. It assumes the state knows better than the patient what they are emotionally equipped to handle—effectively replacing personal choice with state paternalism. Even though the bill permits a physician to communicate results in person, it still bars the patient from exercising autonomy over their own medical data.
• Personal Responsibility: By mandating a three-day delay before disclosing certain test results, the bill undercuts the principle that individuals are best suited to manage their own health outcomes. Rather than encouraging informed, responsible engagement with one's health, it suggests that individuals cannot be trusted to interpret or act upon sensitive information without the guidance of a physician. This removes the burden of decision-making from the individual, which in turn weakens the expectation of self-management and personal accountability.
• Free Enterprise: Although the bill includes immunity for noncompliance and avoids criminal or civil penalties, it does impose procedural obligations on healthcare providers and electronic health record (EHR) system vendors. These entities must reconfigure or monitor systems to comply with a new government mandate. Over time, this could increase compliance costs and reduce flexibility in how providers tailor care to patient preferences. It also discourages innovation in patient-directed digital health tools.
• Private Property Rights: Medical records, particularly those stored and accessed digitally, are considered by many to be a form of personal property. While the bill does not transfer ownership or seize control, it delays access to that property without the patient's consent. This temporary restriction on access—especially when mandated by the state—can be seen as an infringement on one’s control over their own health data.
• Limited Government: The bill exemplifies a policy that extends government authority into private, individualized domains—namely, how and when patients can receive personal health information. Rather than allowing professional medical associations, private entities, or individual patients to establish preferences, it mandates a universal approach from the top down. Even without enforcement penalties, codifying such a rule into law expands the regulatory footprint of the state and undermines the principle that government should be minimal and restrained in scope.

• HB 1699 (Similar To)